Encompass More Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Encompass More Asset Management's CORT Position: Q3 2026 in Review
Encompass More Asset Management opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 5,986 shares worth $690K. The stake represents 0.1% of the portfolio and ranks #125 among its holdings.
503 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Encompass More Asset Management held 5,986 shares of Corcept Therapeutics worth $690K as of Q3 2026.
- Corcept Therapeutics was a new Encompass More Asset Management position in Q3 2026.
- Corcept Therapeutics made up 0.1% of Encompass More Asset Management's portfolio in Q3 2026, its #125 holding.
- 503 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Encompass More Asset Management's 13F filing for Q3 2026, filed 16 Oct 2026.